Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women
Open Access
- 1 February 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (2) , 492-502
Abstract
Epidemiologic studies have consistently reported that endogenous steroid hormone levels are associated with postmenopausal breast cancer risk, but little is known on the associations by tumor grade, hormone receptor status, or age at diagnosis. We performed a case-cohort study of naturally postmenopausal women within the Melbourne Collaborative Cohort Study that included a random sample of 857 women and 197 breast cancer cases diagnosed during a mean of 9.2 years of follow-up. Concentrations of total estradiol, estrone sulfate, testosterone, DHEA sulfate, androstenedione, and sex hormone binding globulin were measured in plasma collected at baseline before diagnosis; free estradiol plasma concentration was calculated. Cox regression was used to estimate associations adjusted for known and potential confounders. The HR for breast cancer comparing fourth and first quartiles was 1.44 [95% confidence interval (95% CI), 0.89-2.35] for total estradiol, 1.75 (95% CI, 1.06, 2.89) for free estradiol, 2.05 (95% CI, 1.24-3.37) for estrone sulfate, 1.25 (95% CI, 0.78-2.01) for testosterone, 1.41 (95% CI, 0.88-2.27) for DHEA sulfate, 1.49 (95% CI, 0.91-2.44) for androstenedione, and 0.33 (95% CI, 0.19-0.55) for sex hormone binding globulin. These associations did not differ by tumor grade and estrogen receptor/progesterone receptor status (all test for heterogeneity, P > 0.05). Risks associated with estrogen and androgen levels were stronger at older ages (test for interaction across age groups, P = 0.59 for total estradiol and P = 0.01 for testosterone). Our prospective study confirms earlier findings and suggests that the associations of endogenous hormones with postmenopausal breast cancer risk are independent of tumor grade, and hormone receptor status and might increase in strength with age. Cancer Epidemiol Biomarkers Prev; 19(2); 492–502Keywords
This publication has 30 references indexed in Scilit:
- Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET CohortCancer Epidemiology, Biomarkers & Prevention, 2009
- Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer riskThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- The role of estrogen in the initiation of breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2006
- Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal WomenJNCI: Journal of the National Cancer Institute, 2006
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinomaCancer, 2004
- Hormone replacement therapy in relation to breast carcinoma incidence rate ratiosCancer, 2004
- Hormonal carcinogenesisCarcinogenesis, 2000
- Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperatureThe Journal of Steroid Biochemistry and Molecular Biology, 1982